tumCV Cancer Research Results

tumCV, Cell Viability: Click to Expand ⟱
Source:
Type:
Cell Viability
Scientific Papers found: Click to Expand⟱
4488- Se,  Chit,  PEG,    Anticancer effect of selenium/chitosan/polyethylene glycol/allyl isothiocyanate nanocomposites against diethylnitrosamine-induced liver cancer in rats
- in-vivo, Liver, HepG2 - in-vivo, Nor, HL7702
tumCV↓, Apoptosis↑, *GSH↑, *VitC↑, *VitE↑, *SOD↑, *GPx↑, *GR↑, ALAT↓, ALP↓, AST↓, LDH↓, selectivity↑, eff↑,
4484- Se,  Chit,  PEG,    Anti-cancer potential of selenium-chitosan-polyethylene glycol-carvacrol nanocomposites in multiple myeloma U266 cells
- in-vitro, Melanoma, U266
tumCV↓, selectivity↑, ROS↑, MMP↓, Apoptosis↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓,
4752- SeNPs,  CUR,  Chemo,    Curcumin-Modified Selenium Nanoparticles Improve S180 Tumour Therapy in Mice by Regulating the Gut Microbiota and Chemotherapy
- in-vitro, Cerv, HeLa - in-vitro, sarcoma, S180
tumCV↓, ROS↑, *GutMicro↑, BioAv↑, other↝, Dose↝,
4473- SeNPs,    Anti-cancerous effect and biological evaluation of green synthesized Selenium nanoparticles on MCF-7 breast cancer and HUVEC cell lines
- in-vitro, BC, MCF7 - in-vitro, Nor, HUVECs
AntiCan↑, selectivity↓, *Bacteria↓, *antiOx↑, *toxicity↓, ROS↑, tumCV↓,
9278- SES, SSM,    Antitumor Effects of Sesamin via the LincRNA-p21/STAT3 Axis in Human Bladder Cancer: Inhibition of Metastatic Progression and Enhanced Chemosensitivity
- vitro+vivo, Bladder, UMUC3 - in-vitro, Bladder, 5637
tumCV↓, MMP2↓, STAT3↓, TumCMig↓, TumCI↓, ChemoSen↑, TumVol↓, TumW↓, Ki-67↓, Synergy↑,
3182- SFN,    Sulforaphane Modulates AQP8-Linked Redox Signalling in Leukemia Cells
- in-vitro, AML, NA
Prx↓, AQPs↓, NOX↓, tumCV↓, AntiCan↑, cardioP↑, neuroP↑, Inflam↓, chemoPv↑, angioG↓, TumMeta↓, selectivity↑, ROS↓,
8778- SFN,    Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells
- in-vitro, Pca, DU145 - in-vitro, Pca, LNCaP
tumCV↓, IL6↓, STAT3↓, Dose↝, JAK2↓, Bcl-2↓, cycD1/CCND1↓, survivin↓, DNAdam↑, chemoPv↑,
2405- SFN,    Sulforaphane Targets the TBX15/KIF2C Pathway to Repress Glycolysis and Cell Proliferation in Gastric Carcinoma Cells
- in-vitro, GC, SGC-7901 - in-vitro, GC, BGC-823
TumCP↓, Glycolysis↓, TBX15↑, GlucoseCon↓, lactateProd↓, tumCV↓, PKM2↓, KIF2C↓,
1463- SFN,    Sulforaphane induces reactive oxygen species-mediated mitotic arrest and subsequent apoptosis in human bladder cancer 5637 cells
- in-vitro, Bladder, 5637
tumCV↓, CycB/CCNB1↑, p‑CDK1↑, Apoptosis↑, Casp8↑, Casp9↑, Casp3↑, cl‑PARP↑, ROS↑, eff↓,
1456- SFN,    Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancreatic cancer cells
- in-vitro, PC, MIA PaCa-2 - in-vitro, PC, PANC1
tumCV↓, TumCP↓, cl‑PARP↑, cl‑Casp3↑, TumCCA↑, ROS↑, MMP↓, γH2AX↑, eff↓, *toxicity↓,
1434- SFN,  GEM,    Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity
- in-vitro, CCA, HuCCT1 - in-vitro, CCA, HuH28 - in-vivo, NA, NA
HDAC↓, ac‑H3↑, ChemoSen↑, tumCV↓, TumCP↓, TumCCA↑, Apoptosis↑, cl‑Casp3↑, TumCI↓, VEGF↓, VEGFR2/KDR/Flk1↓, Hif1a↓, eNOS↓, EMT?, TumCG↓, Ki-67↓, TUNEL↑, P21↑, p‑Chk2↑, CDC25↓, BAX↑, *ROS↓, NQO1?,
1482- SFN,    Sulforaphane induces apoptosis in T24 human urinary bladder cancer cells through a reactive oxygen species-mediated mitochondrial pathway: the involvement of endoplasmic reticulum stress and the Nrf2 signaling pathway
- in-vitro, Bladder, T24/HTB-9
tumCV↓, Apoptosis↑, Cyt‑c↑, Bax:Bcl2↑, Casp9↑, Casp3↑, Casp8∅, cl‑PARP↑, ROS↑, MMP↓, eff↓, ER Stress↑, p‑NRF2↑, HO-1↑,
1480- SFN,    Sulforaphane Induces Cell Death Through G2/M Phase Arrest and Triggers Apoptosis in HCT 116 Human Colon Cancer Cells
- in-vitro, CRC, HCT116
tumCV↓, TumCCA↑, Apoptosis↑, cycA1/CCNA1↑, CycB/CCNB1↑, CDC25↓, CDK1↓, ROS↑, eff↓, Cyt‑c↑, AIF↑, ER Stress↑,
1479- SFN,    Sulforaphane triggers Sirtuin 3-mediated ferroptosis in colorectal cancer cells via activating the adenosine 5'-monophosphate (AMP)-activated protein kinase/ mechanistic target of rapamycin signaling pathway
- in-vitro, CRC, HCT116
Ferroptosis↑, SIRT3↑, AMPK↑, mTOR↑, tumCV↓, ROS↑, MDA↑, Iron↑,
1477- SFN,    Sulforaphane Induces Oxidative Stress and Death by p53-Independent Mechanism: Implication of Impaired Glutathione Recycling
- in-vitro, OS, MG63
tumCV↓, Apoptosis↑, Casp3↑, ROS↑, GSR↓, GPx↓,
1476- SFN,  PDT,    Enhancement of cytotoxic effect on human head and neck cancer cells by combination of photodynamic therapy and sulforaphane
- in-vitro, HNSCC, NA
Synergy↑, tumCV↓, ROS↑, eff↓, Casp↑,
1513- SFN,  acetaz,    Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
- in-vitro, BrCC, H720 - in-vivo, BrCC, NA - in-vitro, BrCC, H727
Synergy↑, tumCV↓, Apoptosis↑, P21↑, PI3K↓, Akt↓, mTOR↓, 5HT↓, NRF2↑,
3304- SIL,    Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells
- in-vitro, GC, AGS - in-vivo, NA, NA
BAX↑, p‑JNK↑, p‑p38↑, cl‑PARP↑, Bcl-2↓, p‑ERK↓, TumVol↓, Apoptosis↑, tumCV↓,
3305- SIL,    Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vivo, NA, NA
TumCP↓, tumCV↓, BAX↑, cl‑PARP↑, Casp9↑, p‑JNK↑, Bcl-2↓, p‑p38↓, p‑ERK↓, *toxicity∅, Dose↝, *hepatoP↑, Inflam↓, AntiCan↑,
3299- SIL,    Silymarin Effect on Mitophagy Pathway in the Human Colon Cancer HT-29 Cells
- in-vitro, Colon, HT29
tumCV↓, MMP↓, ROS↑, selectivity↑,
3290- SIL,    A review of therapeutic potentials of milk thistle (Silybum marianum L.) and its main constituent, silymarin, on cancer, and their related patents
- Analysis, Var, NA
hepatoP↑, chemoP↑, *lipid-P↓, *antiOx↑, tumCV↓, TumCMig↓, Apoptosis↑, ROS↑, GSH↓, Bcl-2↓, survivin↓, cycD1/CCND1↓, NOTCH1↓, BAX↑, NF-kB↓, COX2/PTGS2↓, LOX1↓, iNOS↓, TNF-α↓, IL1↓, Inflam↓, *toxicity↓, CXCR4↓, EGFR↓, ERK↓, MMP↓, Cyt‑c↑, TumCCA↑, RB1↑, P53↑, P21↑, p27/CDKN1B↑, cycE/CCNE↓, CDK4↓, p‑pRB↓, Hif1a↓, cMyc↓, IL1β↓, IFN-γ↓, PCNA↓, PSA↓, CYP1A1↓,
2418- SK,    Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
- in-vitro, HCC, SMMC-7721 cell - in-vitro, HCC, HUH7 - in-vitro, HCC, HepG2
tumCV↓, GlucoseCon↓, lactateProd↓, ChemoSen↑, PKM2↓, Glycolysis↓,
2232- SK,    Shikonin Induces Autophagy and Apoptosis in Esophageal Cancer EC9706 Cells by Regulating the AMPK/mTOR/ULK Axis
- in-vitro, ESCC, EC9706
tumCV↓, TumCMig↓, TumCI↓, TumAuto↑, Apoptosis↑, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑Casp8↑, cl‑PARP↑, AMPK↑, mTOR↑, TumVol↓, OS↑, LC3I↑,
2194- SK,    Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo
- in-vitro, ESCC, Eca109 - in-vitro, ESCC, EC9706 - in-vivo, NA, NA
tumCV↓, TumCCA↑, Apoptosis↑, EGFR↓, PI3K↓, Hif1a↓, PKM2↓, cycD1/CCND1↓, AntiTum↑,
2182- SK,  Cisplatin,    Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway
- in-vitro, Lung, A549 - in-vitro, Lung, PC9 - in-vivo, NA, NA
tumCV↓, TumCP↓, TumCI↓, TumCMig↓, Apoptosis↑, PKM2↓, Glycolysis↓, GlucoseCon↓, lactateProd↓, ChemoSen↑, TumVol↓, TumW↓, GLUT1↓,
2221- SK,    Shikonin Induces Apoptosis, Necrosis, and Premature Senescence of Human A549 Lung Cancer Cells through Upregulation of p53 Expression
- in-vitro, Lung, A549
Apoptosis↑, TumCP↓, tumCV↓, Necroptosis↑, P53↑, ROS↑, NF-kB↓,
3048- SK,    Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, 4T1 - in-vitro, Nor, MCF12A - in-vivo, NA, NA
tumCV↓, selectivity↑, EMT↓, TumCMig↓, TumCI↓, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, β-catenin/ZEB1↓, GSK‐3β↑,
2007- SK,    Shikonin Directly Targets Mitochondria and Causes Mitochondrial Dysfunction in Cancer Cells
- in-vitro, lymphoma, U937 - in-vitro, BC, MCF7 - in-vitro, BC, SkBr3 - in-vitro, CRC, HCT116 - in-vitro, OS, U2OS - NA, Nor, RPE-1
tumCV↓, selectivity↑, Dose↝, other↑, MMP↓, ROS↑, DNAdam↑, Ca+2↑, Casp9↑, Cyt‑c↑, *toxicity↓,
5076- SSE,    Sodium selenite inhibits the growth of cervical cancer cells through the PI3K/AKT pathway
- in-vivo, Cerv, HeLa - in-vivo, Cerv, SiHa
TumCG↓, toxicity↓, tumCV↓, Apoptosis↑, p‑PI3K↓, p‑Akt↓, eff↑,
5086- SSE,    Sodium Selenite Induces Superoxide-Mediated Mitochondrial Damage and Subsequent Autophagic Cell Death in Malignant Glioma Cells
- in-vitro, GBM, U87MG - in-vitro, GBM, T98G - in-vitro, GBM, A172
TumAuto↑, ROS↑, TumCD↑, tumCV↓, selectivity↑, MMP↓, eff↓, MitoP↑,
5084- SSE,  GEM,    The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study
- in-vitro, PC, PANC1 - vitro+vivo, PC, Panc02
tumCV↓, ChemoSen↑, TumCG↓, OS↑, MMP↓, AIF↑, GSH↓, Trx↓, ROS↑, AntiTum↑,
6431- T4O,    Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo
- vitro+vivo, NSCLC, A549
TumCCA↑, Casp3↑, Casp9↑, cl‑PARP↑, MMP↓, Bax:Bcl2↑, XIAP↓, survivin↓, Dose↝, Apoptosis↑, tumCV↓, Cyt‑c↑, eff↑, necrosis↑,
6438- T4O,    Terpinen-4-ol inhibits colorectal cancer growth via reactive oxygen species
- in-vitro, CRC, HCT116
mt-ROS↑, TumCP↑, tumCV↑, eff↓, TumVol↓, selectivity↑,
6432- T4O,    Terpinen-4-ol inhibits colorectal cancer growth via reactive oxygen species
- in-vitro, CRC, HCT116
other↝, Apoptosis↑, mt-ROS↑, eff↓, tumCV↓, TumCP↓, selectivity↑, TumCG↓,
5332- TFdiG,    Theaflavin-3,3′-digallate triggers apoptosis in osteosarcoma cells via the caspase pathway
- vitro+vivo, OS, 143B - in-vitro, OS, U2OS
tumCV↓, cl‑Casp3↑, cl‑Casp9↑, p‑γH2AX↑, BAX↑, Bak↑, Cyt‑c↑, Mcl-1↓, survivin↓, TumVol↓, Wnt↓, β-catenin/ZEB1↓, Dose↝, ROS↑, eff↓, TumW↓, Ki-67↓,
5333- TFdiG,    Theaflavin-3,3′-Digallate Plays a ROS-Mediated Dual Role in Ferroptosis and Apoptosis via the MAPK Pathway in Human Osteosarcoma Cell Lines and Xenografts
- vitro+vivo, OS, MG63
tumCV↓, TumCP↓, TumCCA↑, Iron↑, ROS↑, GSH↓, Fenton↑, Ferroptosis↑, Apoptosis↑, MAPK↑, ERK↑, JNK↑, p38↑, TumCG↓, Dose↝, FTH1↓, GPx4↓,
5222- TQ,    Thymoquinone chemosensitizes colon cancer cells through inhibition of NF-κB
- in-vitro, CRC, COLO205 - in-vitro, CRC, HCT116
tumCV↓, ChemoSen↑, p‑p65↓, NF-kB↓, VEGF↓, cMyc↓, Bcl-2↓, ROS↑,
1308- TQ,    Thymoquinone induces apoptosis via targeting the Bax/BAD and Bcl-2 pathway in breast cancer cells
- in-vitro, BC, MCF7
tumCV↓, TumCP↓, BAX↑, P53⇅, Apoptosis↑,
1929- TQ,    Thymoquinone Suppresses the Proliferation, Migration and Invasiveness through Regulating ROS, Autophagic Flux and miR-877-5p in Human Bladder Carcinoma Cells
- in-vitro, Bladder, 5637 - in-vitro, Bladder, T24/HTB-9
tumCV↓, TumCP↓, TumCI↓, Casp↑, ROS↑, PD-L1↓, EMT↓, MMP↓, eff↓,
1931- TQ,  doxoR,    Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms
- in-vivo, AML, NA
ChemoSen↑, tumCV↓, TumCCA↑, ROS↑, MMP↓, eff↓, TumVol↓, eff↑, Ki-67↓,
2135- TQ,    Thymoquinone induces heme oxygenase-1 expression in HaCaT cells via Nrf2/ARE activation: Akt and AMPKα as upstream targets
- in-vitro, Nor, HaCaT
*HO-1↑, *NRF2↑, *e-ERK↑, *e-Akt↑, *AMPKα↑, *ROS⇅, *eff↓, *tumCV∅,
2099- TQ,  Cisplatin,    Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo
- in-vitro, Lung, H460 - in-vitro, Lung, H146 - in-vivo, NA, NA
ChemoSen↑, TumCP↓, tumCV↓, Apoptosis↑, NF-kB↓,
2105- TQ,    Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation
- in-vitro, PC, AsPC-1 - in-vitro, PC, MIA PaCa-2 - in-vitro, PC, Hs766t - in-vivo, NA, NA
tumCV↓, TumCP↓, TumCCA↑, Apoptosis↑, P53↑, Bcl-2↓, P21↑, ac‑H4↑, HDAC↓, HDAC1↓, HDAC2↓, HDAC3↓, TumVol↓,
2107- TQ,    Cytotoxicity of Nigella sativa seed oil and extract against human lung cancer cell line
- in-vitro, Lung, A549
tumCV↑,
2110- TQ,    Nigella sativa seed oil suppresses cell proliferation and induces ROS dependent mitochondrial apoptosis through p53 pathway in hepatocellular carcinoma cells
- in-vitro, HCC, HepG2 - in-vitro, BC, MCF7 - in-vitro, Lung, A549 - in-vitro, Nor, HEK293
P53↑, lipid-P↑, GSH↓, ROS↑, MMP↓, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, tumCV↓, selectivity↑,
3413- TQ,    Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src‑mediated phosphorylation of EGF receptor tyrosine kinase
- in-vitro, CRC, HCT116
tumCV↓, Apoptosis↓, BAX↑, Bcl-2↓, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, STAT3↓, survivin↓, cMyc↓, cycD1/CCND1↓, p27/CDKN1B↑, P21↑, EGFR↓, ROS↑,
3414- TQ,    Thymoquinone induces apoptosis through inhibition of JAK2/STAT3 signaling via production of ROS in human renal cancer Caki cells
- in-vitro, RCC, Caki-1
tumCV↓, Apoptosis↑, P53↑, BAX↑, Cyt‑c↑, cl‑Casp9↑, cl‑Casp3↑, cl‑PARP↑, Bcl-2↓, Bcl-xL↓, p‑STAT3↓, p‑JAK2↓, STAT3↓, survivin↓, cycD1/CCND1↓, ROS↑, eff↓,
3403- TQ,    A multiple endpoint approach reveals potential in vitro anticancer properties of thymoquinone in human renal carcinoma cells
- in-vitro, RCC, 786-O
tumCV↓, ROS↑, TumCCA↑, eff↓, TumCI↓,
3402- TQ,    Enhanced Apoptosis in Pancreatic Cancer Cells through Thymoquinone-rich Nigella sativa L. Methanol Extract: Targeting NRF2/HO-1 and TNF-α Pathways
- in-vitro, PC, PANC1 - in-vitro, PC, MIA PaCa-2
tumCV↓, NRF2↑, HO-1↑, TNF-α↓,
3415- TQ,    The anti-neoplastic impact of thymoquinone from Nigella sativa on small cell lung cancer: In vitro and in vivo investigations
- in-vitro, Lung, H446
tumCV↓, TumCCA↑, ROS↓, CycB/CCNB1↑, CycD3↑, cycA1/CCNA1↓, cycE/CCNE↓, cDC2↓, antiOx↑, PARP↓, NRF2↓, ARE/EpRE↑, eff↓,

Showing Research Papers: 551 to 600 of 622
Prev Page 12 of 13 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 622

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 2,   NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 1,   antiOx↓, 2,   antiOx↑, 10,   ARE/EpRE↑, 1,   Catalase↓, 7,   Catalase↑, 5,   Fenton↑, 2,   GPx↓, 2,   GPx↑, 2,   GPx1↓, 1,   GPx4↓, 9,   GPx4↑, 1,   GPx4∅, 1,   GSH↓, 22,   GSH↑, 4,   GSH⇅, 1,   GSH∅, 1,   GSH/GSSG↓, 2,   GSR↓, 2,   GSS↑, 1,   GSSG↑, 1,   GSTs↓, 1,   GSTs↑, 1,   H2O2↑, 2,   e-H2O2↓, 1,   i-H2O2∅, 1,   HO-1↓, 6,   HO-1↑, 7,   HO-2↓, 1,   HO-2↑, 1,   Iron↑, 5,   Iron↝, 1,   i-Iron↓, 1,   i-Iron↑, 1,   Keap1↓, 1,   lipid-P↓, 7,   lipid-P↑, 10,   MDA?, 1,   MDA↑, 8,   NOX↓, 1,   NQO1?, 1,   NQO1↓, 1,   NQO1↑, 1,   NRF2↓, 12,   NRF2↑, 9,   p‑NRF2↑, 2,   p66Shc↓, 1,   p66Shc↑, 1,   Prx↓, 1,   ROS?, 3,   ROS↓, 31,   ROS↑, 232,   ROS⇅, 1,   ROS↝, 1,   ROS∅, 3,   i-ROS↑, 1,   mt-ROS↑, 13,   SOD↓, 8,   SOD↑, 4,   SOD1↑, 1,   SOD2↓, 4,   SOD2↑, 4,   TAC↓, 1,   TAC↑, 2,   TBARS↑, 2,   Thiols↓, 2,   Thiols↝, 1,   TKT↓, 1,   Trx↓, 2,   Trx1↑, 1,   TrxR↓, 2,   xCT/SLC7A11↓, 3,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 1,   STEAP3↓, 1,   Tf↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 1,   CDC25↓, 7,   compI↓, 3,   compII↓, 1,   compIII↓, 1,   compV↓, 1,   EGF↓, 2,   ETC↓, 2,   KIF2C↓, 1,   MFN2↓, 1,   mitResp↓, 3,   mitResp↑, 1,   mtDam↑, 28,   OCR↓, 4,   OXPHOS↓, 3,   OXPHOS↑, 3,   PDH↓, 1,   PDH↑, 1,   PINK1↑, 3,   SIRT3↓, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 2,   ACC↓, 2,   p‑ACC↑, 1,   ACLY↓, 1,   ALAT↓, 3,   AMP↑, 1,   AMPK↑, 18,   p‑AMPK↑, 4,   ATP↓, 17,   citrate↓, 1,   ECAR↓, 2,   ECAR↝, 1,   FAO↓, 1,   FASN↓, 3,   FASN↑, 1,   i-FASN↓, 1,   FBPase↑, 1,   G6PD↓, 1,   GAPDH↓, 1,   GLO-I↓, 1,   GLS↑, 1,   glucoNG↑, 1,   glucose↓, 2,   GlucoseCon↓, 9,   GlucoseCon∅, 1,   GlutMet↓, 1,   GlutMet↑, 1,   Glycolysis↓, 25,   GSK‐3β↓, 2,   GSK‐3β↑, 4,   p‑GSK‐3β↓, 4,   Histones↑, 1,   HK2↓, 7,   HMG-CoA↓, 1,   IDH1↑, 1,   lactateProd↓, 12,   lactateProd∅, 1,   LDHA↓, 4,   LDL↓, 1,   lipidLev↓, 1,   lipoGen↓, 2,   NADPH↓, 1,   O-Glc↓, 1,   PDHB↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 4,   PDKs↓, 1,   PFK↓, 2,   PGK1↓, 1,   PKM2↓, 11,   p‑S6↓, 1,   SIRT1↓, 1,   SIRT1↑, 3,   SIRT2↓, 1,   TCA↓, 1,   TS↓, 1,   Warburg↓, 1,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 13,   AIF↝, 1,   APAF1↑, 5,   Apoptosis?, 1,   Apoptosis↓, 8,   Apoptosis↑, 288,   Apoptosis∅, 1,   mt-Apoptosis↑, 2,   ASK1↑, 1,   BAD↓, 1,   BAD↑, 7,   Bak↑, 3,   BAX↓, 2,   BAX↑, 107,   Bax:Bcl2↑, 26,   Bcl-2↓, 112,   Bcl-2↑, 2,   Bcl-xL↓, 20,   Bcl-xL↑, 2,   BID↑, 3,   BIM↑, 2,   BNIP3↑, 1,   BOK↑, 1,   Casp↑, 27,   cl‑Casp↑, 2,   proCasp↑, 1,   cl‑Casp1↑, 1,   Casp12↑, 6,   Casp3↓, 1,   Casp3↑, 155,   cl‑Casp3↓, 1,   cl‑Casp3↑, 40,   proCasp3↓, 1,   proCasp3↑, 1,   pro‑Casp3↓, 1,   CASP4↑, 1,   Casp6↓, 1,   Casp6↑, 2,   Casp7↑, 22,   cl‑Casp7↑, 2,   Casp8↓, 1,   Casp8↑, 30,   Casp8∅, 1,   cl‑Casp8↑, 4,   Casp9↓, 2,   Casp9↑, 82,   cl‑Casp9↑, 17,   cFLIP↓, 3,   Cyt‑c↓, 1,   Cyt‑c↑, 70,   Diablo↑, 1,   DR5↑, 3,   Endon↑, 2,   FADD↑, 2,   Fas↑, 7,   FasL↑, 9,   Ferroptosis↓, 1,   Ferroptosis↑, 16,   cl‑GSDMD↑, 1,   GSDME↑, 1,   GSDME-N↑, 1,   IAP1↓, 1,   iNOS↓, 4,   Mcl-1↓, 14,   MDM2↓, 8,   MLKL↑, 2,   p‑MLKL↓, 1,   MOMP↓, 1,   MOMP↑, 2,   NAIP↓, 1,   Necroptosis↑, 3,   necrosis↑, 4,   NOXA↑, 2,   p38↓, 4,   p38↑, 6,   p‑p38↓, 3,   p‑p38↑, 6,   PDCD4↑, 1,   proApCas↑, 1,   PUMA↑, 4,   Pyro↑, 4,   RIP3↑, 1,   p‑RIP3↑, 2,   survivin↓, 40,   TNFR 1↑, 1,   TRAIL↑, 4,   TRAILR↑, 1,   TumCD↓, 1,   TumCD↑, 19,   TumCD∅, 1,   TUNEL↑, 1,   XIAP↓, 12,   YAP/TEAD↓, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 82,   Akt↑, 4,   p‑Akt↓, 37,   AKT1↓, 2,   Brk/PTK6↓, 1,   CaMKII ↓, 1,   CaMKII ↑, 1,   CIP2A↓, 1,   CK2↓, 1,   cMET↓, 1,   p‑cMET↑, 1,   cSrc↓, 1,   EGFR↓, 19,   p‑EGFR↓, 2,   ERK↓, 23,   ERK↑, 6,   ERK↝, 1,   p‑ERK↓, 12,   p‑ERK↑, 3,   GRB2↓, 1,   HER2/EBBR2↓, 3,   p‑HER2/EBBR2↓, 1,   HRAS↓, 1,   IGF-1R↓, 5,   IKKα↓, 3,   IKKα↑, 1,   p‑IκB↓, 1,   JAK↓, 1,   JAK1↓, 4,   JAK2↓, 9,   p‑JAK2↓, 1,   JNK↓, 4,   JNK↑, 12,   p‑JNK↓, 1,   p‑JNK↑, 6,   LIFR/CD118↓, 1,   MAPK↓, 10,   MAPK↑, 10,   MAPK↝, 1,   p‑MAPK↓, 1,   p‑MAPK↑, 2,   MEK↓, 5,   p‑MEK↑, 1,   MKP1↓, 1,   MKP2↓, 1,   mTOR↓, 47,   mTOR↑, 2,   p‑mTOR↓, 12,   mTORC2↓, 1,   mTORC2↑, 1,   p‑p70S6↓, 1,   P70S6K↓, 1,   p‑P70S6K↓, 2,   PI3K?, 1,   PI3K↓, 54,   PI3K↑, 1,   p‑PI3K↓, 13,   PI3k/Akt/mTOR↓, 2,   PKA↓, 2,   PKCδ↓, 3,   PKCδ↑, 1,   PRKCQ/PKCθ↓, 1,   PTEN↑, 8,   PTK2B / PYK2↓, 1,   e-Raf↓, 1,   RAS↓, 4,   RAS↑, 1,   RCC1↓, 1,   RIP1↓, 1,   Sp1/3/4↓, 6,   Src↓, 1,   STAT↓, 3,   STAT3↓, 40,   STAT3↑, 1,   p‑STAT3↓, 15,   STAT4↓, 1,   STAT4↑, 1,   STAT5↓, 4,   p‑STK11/LKB1↑, 2,   TK1↓, 1,   TSC2↑, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↑, 4,   ChrMod↝, 1,   cJun↓, 1,   p‑cJun↑, 1,   cMyc↓, 16,   cMyc↑, 2,   DNMT1↓, 6,   DNMT3A↓, 4,   DNMT3B↓, 2,   DNMTs↓, 2,   FOXM1↓, 1,   FOXO1↓, 1,   FOXO3↓, 2,   p‑FOXO3↓, 1,   FOXO4↓, 1,   GATA3↑, 1,   ac‑H3↑, 3,   ac‑H3↝, 1,   ac‑H4↑, 3,   HATs↓, 1,   HDAC↓, 8,   HDAC1↓, 4,   HDAC2↓, 4,   HDAC3↓, 2,   HDAC6↓, 1,   HMTs↓, 2,   JHDM1D-AS1↓, 1,   miR-107↑, 1,   miR-139-5p↑, 1,   miR-148a↑, 1,   miR-149↑, 1,   miR-155↓, 2,   miR-21↓, 2,   miR-22↑, 1,   miR-224↓, 1,   miR-27a-3p↓, 1,   miR-340↓, 1,   miR-34a↓, 1,   miR-34a↑, 2,   miR-422a↑, 1,   miR-542↓, 1,   Myc↓, 2,   OCT4↓, 6,   other↓, 1,   other↑, 3,   other↝, 9,   SALL4↓, 1,   SBF2-AS1↓, 1,   sonoS↑, 1,   SOX2↓, 6,   SOX4↓, 1,   SUV39H↓, 2,   TBX15↑, 1,   TET3↑, 1,   TLE1↓, 1,   tumCV?, 6,   tumCV↓, 593,   tumCV↑, 11,   tumCV∅, 7,   UTF1↑, 1,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 4,   c-ATF6↑, 1,   CHOP/DDIT3↑, 20,   eIF2α↑, 3,   p‑eIF2α↑, 5,   ER Stress↓, 1,   ER Stress↑, 32,   ERStress↑, 1,   GRP78/BiP↑, 16,   GRP94↑, 4,   HSF1↓, 1,   HSP27↝, 1,   HSP70/HSPA5↓, 4,   HSP70/HSPA5↑, 1,   HSP70/HSPA5⇅, 1,   HSP70/HSPA5↝, 1,   HSP90↓, 4,   IRE1↑, 2,   PERK↑, 3,   p‑PERK↑, 4,   Proteasome↓, 1,   SERPINH1/HSP47↓, 1,   UPR↑, 3,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 4,   ATG7↑, 1,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 11,   CTSB↓, 2,   CTSD↓, 2,   LC3A↑, 1,   LC3B↑, 5,   LC3B-II↑, 2,   LC3I↑, 2,   LC3II↑, 11,   LC3s↑, 1,   MitoP↑, 3,   p62↓, 6,   p62↑, 4,   PARK2↑, 3,   SESN2↑, 1,   TumAuto↓, 4,   TumAuto↑, 41,   p‑ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 2,   p‑ATM↑, 1,   ATR↑, 1,   BRCA1↓, 2,   BRCA1↑, 1,   DFF45↑, 1,   DNA-PK↑, 1,   DNAdam↓, 1,   DNAdam↑, 65,   DNArepair↓, 1,   hTERT/TERT↓, 3,   Ku70/XRCC6↓, 1,   NHEJ↓, 1,   P53?, 1,   P53↓, 2,   P53↑, 57,   P53⇅, 1,   P53↝, 1,   p‑P53↑, 3,   p53 Wildtype↓, 1,   PARP↓, 5,   PARP↑, 15,   p‑PARP↑, 1,   cl‑PARP↓, 3,   cl‑PARP↑, 54,   PARP1↑, 2,   cl‑PARP1↑, 3,   PCNA↓, 14,   POLD1↓, 1,   SIRT6↑, 1,   Telomerase↓, 5,   TOP1↓, 1,   TOP2↓, 3,   TP53↑, 1,   TRF2↓, 1,   XRCC1↓, 1,   γH2AX↑, 7,   p‑γH2AX↑, 3,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 10,   CDK1↑, 1,   p‑CDK1↑, 1,   CDK2↓, 11,   CDK2↑, 1,   CDK4↓, 16,   CDK4↑, 1,   CDK6↓, 9,   CDK6↑, 1,   CDK8↓, 1,   CHK1↓, 1,   Chk2↑, 1,   p‑Chk2↑, 1,   ChrCon↑, 2,   cycA1/CCNA1↓, 6,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 11,   CycB/CCNB1↑, 3,   cycD1/CCND1↓, 48,   CycD3↓, 3,   CycD3↑, 1,   cycE/CCNE↓, 14,   cycE1↓, 2,   E2Fs↓, 2,   Ki-67↓, 19,   mitA↑, 2,   MKI67↑, 1,   P21?, 1,   P21↓, 4,   P21↑, 35,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 13,   PLK1↓, 1,   pRB↓, 1,   p‑pRB↓, 1,   RB1↓, 2,   RB1↑, 1,   p‑RB1↓, 2,   Securin↓, 1,   TumCCA?, 3,   TumCCA↓, 2,   TumCCA↑, 157,   TumCCA⇅, 1,   TumCCA∅, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 2,   ALDH↓, 3,   ALDH1A1↓, 1,   Axin2↓, 1,   BMI1↓, 1,   BMPs↑, 1,   CD133↓, 5,   CD24↓, 2,   CEBPA↑, 1,   cFos↓, 2,   CSCs↓, 17,   CSCsMark↓, 1,   Diff↓, 1,   Diff↑, 1,   HH↓, 3,   HMGCR↓, 1,   IGF-1?, 1,   IGF-1↓, 6,   Ki-67↓, 19,   LRP6↓, 1,   mTORC1↓, 4,   Nanog↓, 4,   Nestin↓, 2,   NOTCH↓, 3,   NOTCH1↓, 3,   NOTCH3↓, 1,   Piezo1↑, 1,   Shh↓, 1,   STAT1↓, 1,   TAZ↓, 1,   TumCG?, 2,   TumCG↓, 81,   TumCG↑, 2,   TumCG∅, 1,   TumCP↓, 116,   TumCP↑, 2,   Wnt↓, 14,   Wnt/(β-catenin)↓, 4,  

Migration(tgid=13) ⓘ

AKR1C2↓, 1,   Alix/AIP‑1↓, 1,   annexin II↓, 1,   AntiAg↑, 1,   AP-1↓, 1,   APC↑, 1,   Ca+2↓, 2,   Ca+2↑, 20,   Ca+2↝, 5,   i-Ca+2↓, 1,   i-Ca+2↑, 4,   Cal1↑, 2,   cal2↑, 1,   Cav1↓, 1,   CCN2/CTGF↓, 1,   Cofilin↓, 1,   p‑Cofilin↑, 2,   COL1↓, 1,   COL4↓, 1,   CTNNB1↓, 1,   E-cadherin↓, 3,   E-cadherin↑, 14,   EMT?, 1,   EMT↓, 31,   F-actin↓, 1,   F-actin↑, 1,   FAK↓, 3,   p‑FAK↓, 1,   Fibronectin↓, 2,   IQGAP3↓, 1,   KRAS↓, 4,   LEF1↓, 1,   MET↑, 1,   MMP1↓, 4,   MMP16↓, 1,   MMP2↓, 37,   MMP3↓, 3,   MMP7↓, 4,   MMP7∅, 1,   MMP9↓, 32,   MMP9:TIMP1↓, 1,   MMPs↓, 12,   N-cadherin↓, 8,   N-cadherin↑, 2,   PAK1↓, 2,   proline↓, 1,   Rac1↓, 2,   Rho↓, 1,   Rho↑, 1,   Slug?, 1,   Slug↓, 7,   SMAD2↓, 1,   SMAD3↓, 3,   Snail?, 1,   Snail↓, 9,   Snail↑, 1,   TET1↑, 3,   TGF-β↓, 3,   TIMP1↑, 3,   TIMP2↓, 1,   TIMP2↑, 2,   TRIB3↑, 1,   TumCA↓, 1,   TumCI↓, 78,   TumCMig↓, 98,   TumCMig↑, 1,   TumCMig⇅, 1,   TumMeta↓, 28,   TumMeta↑, 3,   Twist↓, 7,   TXNIP↑, 1,   uPA↓, 2,   Vim?, 1,   Vim↓, 12,   Vim↑, 2,   Zeb1↓, 2,   α-SMA↓, 1,   α-SMA↑, 2,   β-catenin/ZEB1↓, 24,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 27,   angioG↑, 1,   CD31/PECAM-1↓, 1,   Endoglin↑, 2,   eNOS↓, 1,   HIF-1↓, 4,   Hif1a↓, 17,   Hif1a↑, 1,   LOX1↓, 1,   NO↓, 1,   VCAM-1↓, 1,   VEGF↓, 34,   VEGFR2/KDR/Flk1↓, 4,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 2,   BBB↑, 1,   BBB∅, 1,   CellMemb↓, 1,   EPR↑, 4,   GLUT1↓, 5,   MMP?, 1,   MMP↓, 105,   MMP↑, 2,   MMP∅, 1,   MPT↑, 5,   NHE1↓, 1,   SLC6A3?, 1,   sonoP↑, 2,   TRPM7↓, 3,   TRPV1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 2,   CCR7↓, 1,   CD4+↑, 6,   CD44↓, 4,   CD8+↑, 7,   cDC2↓, 2,   COX1↓, 2,   COX2/PTGS2↓, 23,   COX2/PTGS2↑, 2,   CXCc↓, 1,   CXCR3↓, 1,   CXCR4↓, 2,   DR4↑, 3,   FOXP3↑, 1,   Gal-3↓, 1,   HMGB1↓, 2,   IFN-γ↓, 2,   IL1↓, 1,   IL1↑, 1,   IL10↓, 1,   IL17↓, 1,   IL18↓, 1,   IL1β↓, 8,   IL1β↑, 1,   IL4↓, 1,   IL6↓, 21,   IL8↓, 4,   Imm↑, 10,   Inflam↓, 22,   MCP1/CCL2↓, 1,   MIP2↓, 1,   MyD88↑, 1,   NF-kB↓, 66,   NF-kB↑, 3,   NF-kB↝, 1,   p‑NF-kB↑, 1,   NK cell↑, 1,   NLRP3↓, 2,   NLRP3↑, 2,   p50↓, 1,   p65↓, 4,   p‑p65↓, 3,   PD-1↓, 1,   PD-L1↓, 5,   PD-L1↑, 1,   PGE2↓, 5,   PSA↓, 2,   T-Cell↑, 1,   TCF↓, 2,   Th1 response↑, 1,   TLR4↓, 3,   TLR4↑, 1,   TNF-α↓, 16,   TNF-α↑, 5,   TRAF2↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   GGT/CD224↑, 1,   pH↓, 1,   pH↑, 3,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 2,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↓, 1,   AR↓, 3,   CYP11A1↓, 1,   DHT↓, 1,   ER-α36↓, 2,   ER-α36↝, 1,   ERβ/ESR2↑, 1,   Estro↝, 1,   EstroRS/ERS↓, 1,   HSD3B↓, 1,   PPARγ↑, 6,   RANKL↓, 1,   SRD5A1↑, 1,   StAR↓, 1,   testos↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 10,   BioAv↑, 13,   BioAv↝, 3,   BioEnh↑, 1,   ChemoSen↑, 85,   CompStab↓, 1,   CYP1A1↓, 2,   CYP1A1↑, 1,   CYP1B1↓, 1,   Dose?, 2,   Dose↓, 3,   Dose↑, 1,   Dose⇅, 1,   Dose↝, 60,   Dose∅, 6,   eff?, 2,   eff↓, 75,   eff↑, 52,   eff⇅, 1,   eff↝, 5,   eff∅, 2,   Half-Life↓, 4,   Half-Life↝, 1,   MDR1↓, 2,   MDR1↑, 1,   MRP1/ABCC1↓, 1,   MRP5↓, 1,   P-gp/ABCB1↓, 8,   RadioS↑, 19,   selectivity?, 4,   selectivity↓, 2,   selectivity↑, 120,   selectivity∅, 1,   Synergy↑, 46,   TET2↓, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 3,   ALP↓, 1,   AR↓, 3,   AST↓, 2,   BRCA1↓, 2,   BRCA1↑, 1,   CRP↓, 1,   EGFR↓, 19,   p‑EGFR↓, 2,   EstroRS/ERS↓, 1,   FOXM1↓, 1,   HER2/EBBR2↓, 3,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 3,   IL6↓, 21,   KRAS↓, 4,   LDH↓, 5,   LDH↑, 6,   Myc↓, 2,   PD-L1↓, 5,   PD-L1↑, 1,   PSA↓, 2,   TG/TAG↓, 1,   TP53↑, 1,   TRIB3↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1,   AntiCan↑, 37,   AntiCan⇅, 1,   AntiDiabetic↑, 1,   antiNeop↑, 3,   AntiTum↑, 14,   AntiTum⇅, 1,   cardioP↑, 5,   chemoP↓, 1,   chemoP↑, 10,   chemoPv↑, 13,   ChemoSideEff↓, 2,   fatigue↓, 1,   FTO↓, 1,   hepatoP↑, 2,   Mucositis↓, 1,   neuroP↑, 5,   OS↑, 9,   Pain↓, 1,   QoL↑, 1,   radioP↑, 3,   RenoP↑, 1,   Risk↓, 3,   Sleep↑, 1,   TGFβR1↓, 1,   toxicity↓, 16,   toxicity↝, 3,   toxicity∅, 1,   TumNum↓, 1,   TumVol↓, 34,   TumVol↑, 1,   TumVol∅, 1,   TumW↓, 17,   TumW∅, 1,   Weight↑, 1,   Weight∅, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 8,  
Total Targets: 843

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 46,   Bil↓, 1,   Catalase↑, 14,   Fenton↓, 1,   GPx↑, 10,   GPx1↑, 1,   GPx4↑, 1,   GSH↓, 1,   GSH↑, 15,   GSR↑, 1,   GSTs↑, 6,   HO-1↓, 1,   HO-1↑, 7,   Iron↑, 1,   Keap1↓, 1,   lipid-P↓, 11,   MDA↓, 9,   MPO↓, 1,   NOX↓, 1,   NOX4↓, 1,   Nrf1↑, 1,   NRF2↑, 13,   RNS↓, 2,   ROS↓, 32,   ROS↑, 5,   ROS⇅, 1,   ROS∅, 1,   SOD?, 1,   SOD↑, 13,   SOD1↑, 1,   TAC↑, 1,   TBARS↓, 1,   Trx1↑, 1,   uricA↓, 1,   VitC↑, 2,   VitE↓, 1,   VitE↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

mitResp↓, 1,   OXPHOS↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 2,   ALAT↓, 7,   AMPK↓, 1,   ATP↓, 1,   DGAT1↓, 1,   FASN↓, 1,   glucose↓, 1,   Glycolysis↑, 1,   GSK‐3β↓, 1,   HK2↑, 1,   NAD↓, 1,   NADPH↓, 2,   PFKL↑, 1,   PFKM↑, 1,   PKM2↑, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 4,   Apoptosis↑, 1,   BAX↓, 2,   Bax:Bcl2↑, 1,   Bcl-2↓, 1,   Bcl-2↑, 2,   Bcl-xL↑, 1,   Casp3↓, 7,   Casp3↑, 1,   proCasp3↓, 1,   Casp8↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 3,   Casp9↑, 1,   Cyt‑c↓, 2,   Fas↑, 1,   Ferroptosis↑, 1,   iNOS↓, 3,   p38↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 1,   e-Akt↑, 1,   AMPKα↑, 1,   p‑CREB↑, 1,   ERK↑, 1,   e-ERK↑, 1,   IKKα↑, 1,   JAK2↑, 1,   PI3K↑, 1,   STAT↓, 1,   STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↓, 1,   other↝, 3,   RUNX2↑, 1,   tumCV↓, 5,   tumCV↑, 1,   tumCV∅, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   LC3II↓, 1,   p62↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   DNAdam↑, 1,   P53↓, 1,   P53↑, 1,   PARP↑, 1,   cl‑PARP↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   cycA1/CCNA1↓, 1,   cycE/CCNE↑, 1,   GADD34↓, 1,   P21↓, 1,   P21↑, 3,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMP2↑, 1,   TumCG↓, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 3,   AP-1↓, 1,   Ca+2↓, 1,   Cartilage↑, 1,   COL1↑, 1,   LRP1↑, 1,   MUC1↑, 1,   p‑Rac1↓, 1,   TGF-β↓, 1,   TumCI↓, 1,   TumCMig↓, 1,   TumCMig↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 2,   NO↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   CellMemb↑, 1,   GastroP↑, 1,   GLUT1↑, 1,   IBI↑, 1,   MMP↓, 1,   MMP↑, 1,   VGSC↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 1,   COX2/PTGS2↓, 7,   FOXP3↑, 1,   HMGB1↓, 1,   IFN-γ↓, 1,   IL1↓, 1,   IL10↓, 3,   IL10↑, 2,   IL17↓, 2,   IL1β↓, 6,   IL4↑, 1,   IL6↓, 8,   Imm↓, 1,   Imm↑, 2,   Inflam↓, 39,   Inflam↑, 1,   M2 MC↑, 1,   MCP1/CCL2↓, 2,   NeuroI↓, 1,   NF-kB?, 1,   NF-kB↓, 8,   NK cell↑, 1,   NLRP3↓, 3,   PGE2↓, 5,   PSA∅, 1,   RAGE↓, 1,   TNF-α↓, 12,   Treg lymp↝, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   AChE↓, 1,   BDNF↓, 1,   MAOA↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 4,   tau↓, 2,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

GR↑, 2,   testos↑, 1,   VDR↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 5,   BioAv↑, 5,   BioAv↝, 3,   ChemoSen↑, 1,   CompStab↝, 1,   CYP2E1↓, 1,   Dose?, 1,   Dose↓, 1,   Dose↑, 1,   Dose↝, 6,   eff↓, 1,   eff↑, 6,   Half-Life↑, 1,   Half-Life↝, 1,   P-gp/ABCB1↓, 1,   Synergy↑, 6,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 7,   ALP↓, 3,   AST↓, 6,   Bil↓, 1,   BloodF↑, 1,   BMD↑, 1,   BP↓, 2,   CEA↓, 1,   creat↓, 1,   IL6↓, 8,   LDH↓, 1,   PSA∅, 1,   RAGE↓, 1,   SpO2↑, 1,   Urea↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   antiAll↑, 7,   AntiArt↑, 3,   AntiCan↑, 5,   AntiDiabetic↑, 11,   antiNeop↑, 1,   AntiTum↑, 3,   Bone Healing↑, 1,   cardioP↑, 11,   chemoP↑, 5,   chemoPv↑, 2,   cognitive↓, 1,   cognitive↑, 2,   cough?, 1,   diuretic↑, 1,   hepatoP↑, 13,   memory↑, 3,   neuroP↑, 17,   Obesity↓, 3,   OS↑, 1,   Pain↓, 3,   RenoP↑, 2,   SoreThr?, 1,   Stress↓, 1,   toxicity↓, 21,   toxicity↑, 1,   toxicity↝, 6,   toxicity∅, 5,   Weight↑, 1,   Wound Healing↑, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 5,   AntiFungal↑, 1,   AntiP↑, 3,   AntiViral↑, 3,   Bacteria↓, 8,   GutMicro↑, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 241

Scientific Paper Hit Count for: tumCV, Cell Viability
22 Silver-NanoParticles
17 Quercetin
14 Cisplatin
14 Sulforaphane (mainly Broccoli)
14 Thymoquinone
12 Curcumin
11 Honokiol
10 doxorubicin
10 Licochalcone A
9 Dandelion Root
9 Fisetin
9 Kaempferol
9 Magnetic Fields
9 Methylsulfonylmethane
9 Phenethyl isothiocyanate
8 Betulinic acid
8 Marjoram (Origanum majorana)
7 SonoDynamic Therapy UltraSound
7 Berberine
7 Capsaicin
7 Carvacrol
7 Eugenol
7 Cynaropicrin
7 Gallic acid
7 Luteolin
7 Shikonin
6 Cynara scolymus/Globe Artichoke/Artichoke Extract
6 Allicin (mainly Garlic)
6 Radiotherapy/Radiation
6 Chrysin
6 Resveratrol
6 Emodin
6 Hyperoside
6 Ivermectin
6 Morin
5 Allyl isothiocyanate
5 Melatonin
5 5-fluorouracil
5 chaetocin
5 Crocetin
5 Formononetin
5 Ginkgetin
5 isoquercitrin
5 Licorice
5 Linalool
5 Matrine
5 Magnetic Field Rotating
5 Phycocyanin
5 Rosmarinic acid
4 Apigenin (mainly Parsley)
4 Metformin
4 Artemisinin
4 Baicalein
4 Berbamine
4 Biochanin A
4 Gemcitabine (Gemzar)
4 Benzyl isothiocyanate
4 Caffeic Acid Phenethyl Ester (CAPE)
4 Chlorogenic acid
4 Carvone
4 Eurycomanone
4 Shilajit/Fulvic Acid
4 Graviola
4 Magnolol
4 iodine
4 Juglone
4 Lycopene
4 Terpinen-4-ol / Tea Tree Oil
4 Propolis -bee glue
4 α-Santalol/Sandalwood oil
4 Silymarin (Milk Thistle) silibinin
4 Vitamin C (Ascorbic Acid)
4 Vitexin
3 Ashwagandha(Withaferin A)
3 Astaxanthin
3 Beta-Caryophyllene
3 Carnosic acid
3 chitosan
3 Selenium
3 Citric Acid
3 CUSP9
3 Chlorella (Chlorella vulgaris)
3 Dichloroacetate
3 tamoxifen
3 Echinacea
3 eicosapentaenoic acid
3 Evodiamine
3 Fucoidan
3 Gambogic Acid
3 Hibiscus sabdariffa
3 Hyperthermia
3 HydroxyTyrosol
3 Methylene blue
3 mebendazole
3 Mushroom Chaga, Inonotus obliquus
3 Nimbolide
3 Piperlongumine
3 Plumbagin
3 Parthenolide
3 Selenite (Sodium)
3 Urolithin
2 3-bromopyruvate
2 Alpha-Lipoic-Acid
2 Anethole/trans-Anethole
2 Aloe anthraquinones
2 Bacopa monnieri
2 Boswellia (frankincense)
2 Beetroot
2 brusatol
2 Caffeic acid
2 Centella asiatica / Gotu kola → asiaticoside
2 Cichoric acid / Chicoric acid
2 Coenzyme Q10
2 Polyphenols
2 Copper and Cu NanoParticles
2 Hydroxycinnamic-acid
2 Indole-3-carbinol
2 D-limonene
2 EGCG (Epigallocatechin Gallate)
2 Garcinol
2 Ginkgolic acids
2 Ginkgo biloba
2 Geraniol
2 Helleborus niger extracts – Christmas Rose
2 Rutin
2 Isoliquiritigenin
2 Isorhamnetin
2 isoorientin
2 Lasiodin
2 SDG/lignans
2 Lutein
2 Gold NanoParticles
2 Iron
2 Mushroom Lion’s Mane, Hericium erinaceus
2 Mushroom Maitake
2 Naringin
2 Purple Corn / Purple Maize
2 Piperine
2 salinomycin
2 polyethylene glycol
2 Selenium NanoParticles
2 Chemotherapy
2 Photodynamic Therapy
2 Aflavin-3,3′-digallate
2 Ursolic acid
2 VitK3,menadione
2 Zerumbone
1 1,8-Cineole
1 Resiquimod
1 DTS(dibenzyl trisulphide) from Anamu
1 Andrographis
1 Ascorbyl Palmitate
1 Trastuzumab
1 Atorvastatin
1 Bevacizumab (brand Avastin)
1 borneol
1 Boron
1 α-Bisabolol / Chamomile oil
1 Bullatacin
1 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
1 hydroxychloroquine
1 Catechins
1 Cannabidiol
1 Selenate
1 Vitamin E
1 Cranberry
1 Docosahexaenoic Acid
1 Diindolylmethane
1 Disulfiram
1 Ellagic acid
1 Cannabichromene
1 Ginkgo biloba-EGb 761
1 Electrical Pulses
1 Estrogen
1 Ferulic acid
1 Fenbendazole
1 Fennel Oil/Foeniculum vulgare
1 olaparib/LYNPARZA
1 Genistein (soy isoflavone)
1 Ginseng
1 γ-linolenic acid (Borage Oil)
1 Hydrogen Gas
1 HydroxyCitric Acid
1 Paclitaxel/Taxol
1 Isobavachalcone
1 Inositol
1 MCT, metronomic chemo
1 capecitabine
1 Isothiocyanates
1 itraconazole
1 L-Theanine
1 Lactobacillus
1 lambertianic acid
1 Lapachol
1 Lemongrass Extract/Citral
1 Folic Acid, Vit B9
1 MBE, Maqui berry
1 gefitinib, erlotinib
1 Modified Citrus Pectin
1 irinotecan
1 Methyl Jasmonate
1 methylseleninic acid
1 Methyl salicylate / Sweet Birch oil
1 Aspirin
1 immunotherapy
1 Magnesium
1 Mangiferin
1 magnetic nanoparticles
1 Lemon Balm/Melissa officinalis
1 Moringa oleifera
1 Bicarbonate(Sodium)
1 Niclosamide (Niclocide)
1 Oleuropein
1 Patchouli Oil (Pogostemon cablin)
1 Phenylbutyrate
1 Propyl gallate
1 Pterostilbene
1 Perilla
1 Scoulerine
1 Sesamin
1 acetazolamide
1 triptolide
1 Triphala
1 Turmerones
1 Vitamin D3
1 Vitamin K2
1 Whole Body Vibration
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:897  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page